China Clears Its First Microarray Platform for in Vitro Diagnostics to Accelerate Personalized Medicine

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix GeneChip System 3000Dx v.2 cleared by China's SFDA for in vitro diagnostic use to enable and accelerate array-based diagnostics for personalized medicine.

Feed Date: 
February 15, 2012